Johns Hopkins
Previse Ramps up Commercialization of Barrett's Esophagus Test, Developing Esophageal Cancer Assay
Premium
The company currently offers a risk stratification test for Barrett's esophagus and is developing an early detection test for esophageal cancer.
Gene Variant Test Shows Promise for Improving Accuracy of CA19-9 for Pancreatic Cancer Detection
Premium
Investigators are assessing performance in a prospective cohort with hopes that the method can be used to complement currently used imaging surveillance.
The method, called GEMINI, improved detection of both overall cancer and the earliest-stage cancers when added to the firm's existing platform.
The preprint raised concerns about the findings of a 2020 cancer microbiome study that spurred the development of a microbiome-based liquid biopsy test for cancer.
Gates Foundation Awards Multiple Grants for Omics, Dx Projects in July
Awardees include BioCrucible, PATH, Johns Hopkins University, 4basebio, Atila Biosystems, Essenlix, Claremont Biosolutions, and the KEMRI – Wellcome Trust Research Program.